Parallax Volatility Advisers, L.P. Amarin Corp Plcuk Call Options Transaction History

Parallax Volatility Advisers, L.P.

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$1.07 - $1.34 $963,000 - $1.21 Million	900,000 New	900,000 $1.09 Million
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $222,912 - $356,384	-68,800 Reduced 99.85%	100 $0
Q3 2021 Nov 15, 2021	SELL	$3.94 - $5.84 $31,914 - $47,304	-8,100 Reduced 10.52%	68,900 $352,000
Q2 2021 Aug 16, 2021	BUY	$4.26 - $6.5 $51,120 - $78,000	12,000 Added 18.46%	77,000 $338,000
Q1 2021 May 14, 2021	SELL	$5.03 - $8.8 $449,179 - $785,840	-89,300 Reduced 57.87%	65,000 $404,000
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $569,236 - $748,179	140,900 Added 1051.49%	154,300 $753,000
Q3 2020 Nov 13, 2020	BUY	$3.64 - $7.76 $48,776 - $103,984	13,400 New	13,400 $56,000
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $119,500 - $206,500	-25,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $319,600 - $1.72 Million	-79,900 Reduced 76.17%	25,000 $100,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $751,366 - $1.3 Million	-53,900 Reduced 33.94%	104,900 $2.25 Million
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $608,382 - $1.01 Million	43,800 Added 38.09%	158,800 $2.41 Million
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $244,050 - $307,650	15,000 Added 15.0%	115,000 $2.23 Million
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $378,300 - $669,900	30,000 Added 42.86%	100,000 $2.08 Million
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $150,161 - $278,058	12,100 Added 20.9%	70,000 $953,000
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $141,855 - $942,033	57,900 New	57,900 $942,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.